Sica, Simona
 Distribuzione geografica
Continente #
NA - Nord America 16.274
AS - Asia 13.294
EU - Europa 11.622
SA - Sud America 2.741
AF - Africa 446
OC - Oceania 205
Continente sconosciuto - Info sul continente non disponibili 17
Totale 44.599
Nazione #
US - Stati Uniti d'America 15.736
SG - Singapore 6.118
CN - Cina 2.911
DE - Germania 2.727
IT - Italia 2.210
BR - Brasile 2.202
SE - Svezia 1.750
FR - Francia 1.157
VN - Vietnam 1.129
GB - Regno Unito 748
IN - India 647
IE - Irlanda 633
UA - Ucraina 555
ID - Indonesia 462
JP - Giappone 380
FI - Finlandia 352
RU - Federazione Russa 320
CA - Canada 298
HK - Hong Kong 270
AR - Argentina 210
ES - Italia 194
PL - Polonia 193
NL - Olanda 192
KR - Corea 187
TR - Turchia 184
AU - Australia 179
BD - Bangladesh 173
IQ - Iraq 167
MX - Messico 150
ZA - Sudafrica 102
AT - Austria 85
SA - Arabia Saudita 77
EC - Ecuador 76
IR - Iran 70
BE - Belgio 67
PK - Pakistan 64
CI - Costa d'Avorio 60
CO - Colombia 60
CZ - Repubblica Ceca 58
VE - Venezuela 58
EG - Egitto 53
MA - Marocco 52
UZ - Uzbekistan 48
KE - Kenya 46
RO - Romania 45
CH - Svizzera 44
PH - Filippine 40
CL - Cile 35
HU - Ungheria 35
NP - Nepal 35
PY - Paraguay 35
BG - Bulgaria 34
TH - Thailandia 34
AE - Emirati Arabi Uniti 33
IL - Israele 32
MY - Malesia 32
DZ - Algeria 30
JO - Giordania 29
PT - Portogallo 29
LT - Lituania 27
NO - Norvegia 27
TW - Taiwan 27
UY - Uruguay 25
NZ - Nuova Zelanda 24
LB - Libano 23
PE - Perù 22
AZ - Azerbaigian 21
TN - Tunisia 20
GR - Grecia 19
ET - Etiopia 17
KZ - Kazakistan 17
RS - Serbia 17
JM - Giamaica 16
SK - Slovacchia (Repubblica Slovacca) 16
BO - Bolivia 13
DO - Repubblica Dominicana 13
SN - Senegal 12
AL - Albania 11
HR - Croazia 11
PA - Panama 11
TT - Trinidad e Tobago 11
AO - Angola 10
BA - Bosnia-Erzegovina 10
OM - Oman 10
DK - Danimarca 9
AM - Armenia 8
BZ - Belize 8
KG - Kirghizistan 8
MD - Moldavia 8
QA - Qatar 8
CR - Costa Rica 7
GE - Georgia 7
LK - Sri Lanka 7
LY - Libia 7
PR - Porto Rico 7
BY - Bielorussia 6
EU - Europa 6
GA - Gabon 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
Totale 44.476
Città #
Singapore 3.041
Ashburn 1.594
Chandler 1.542
San Jose 1.533
Dublin 618
Beijing 572
Jacksonville 411
Jakarta 409
Los Angeles 405
Milan 402
Lauterbourg 385
San Mateo 369
Ho Chi Minh City 361
Hefei 341
Rome 327
Wilmington 307
Hanoi 306
Dearborn 304
Tokyo 288
New York 275
Woodbridge 275
Ann Arbor 267
Nanjing 256
Houston 249
Frankfurt am Main 245
Boston 236
Munich 233
Hong Kong 232
São Paulo 202
Moscow 200
Redwood City 199
Chicago 195
Hyderabad 193
Dallas 192
Princeton 189
Seattle 185
Cattolica 174
Fairfield 161
Council Bluffs 160
The Dalles 141
Lancaster 138
St Louis 131
Nürnberg 130
Buffalo 126
Helsinki 123
Santa Clara 123
Lawrence 120
Marseille 116
Redmond 114
Oviedo 112
Nanchang 110
Seoul 110
Warsaw 109
Kent 97
Orem 96
Hangzhou 94
Toronto 93
Paris 91
Boardman 86
Bremen 84
London 77
Brooklyn 76
Izmir 75
Shanghai 66
Tianjin 66
Florence 64
Phoenix 64
Baghdad 63
San Francisco 63
Amsterdam 62
Brussels 62
Rio de Janeiro 62
Atlanta 61
Da Nang 61
Abidjan 60
Norwalk 60
Lappeenranta 59
Mountain View 58
Nuremberg 58
Belo Horizonte 53
Curitiba 53
Johannesburg 53
Chennai 51
Guangzhou 51
Cambridge 49
Kunming 49
Hebei 47
Washington 46
Manchester 45
Mexico City 45
Montreal 45
Naples 45
Pune 44
Shenyang 44
Denver 43
Dhaka 43
Zhengzhou 42
Tashkent 41
Sydney 40
Zawidów 40
Totale 22.363
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.277
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 371
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 332
Dasatinib first-line: Multicentric Italian experience outside clinical trials 295
Dasatinib first-line: Multicentric Italian experience outside clinical trials 294
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
comparison of haploidentical bone marrow versus matchet unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute leukemia 290
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 228
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 227
Correlation between paraproteinaemia and viral reactivation after allo-SCT 215
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 209
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 201
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 201
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 192
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 188
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 188
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 184
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 179
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 177
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 176
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 175
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 173
Clonal evolution in therapy-related neoplasms 173
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 172
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 168
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 168
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 165
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 164
Work related acute leukemia and mucor mycosis in a boat-builder 162
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 160
The sac evolution imaging follow-up after endovascular aortic repair: An international expert opinion-based Delphi consensus study 159
Hyperleukocytosis and leukostasis: management of a medical emergency 159
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 157
Neurologic improvement after peripheral blood stem cell transplantation in poems 156
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 156
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 155
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 155
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 153
Outcomes of Off the Shelf Outer Branched Versus Inner Branched Endografts in the Treatment of Thoraco-Abdominal Aortic Aneurysm in the B.R.I.O. (BRanched Inner – Outer) Study Group 152
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 152
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 152
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 149
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 149
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 149
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 148
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 148
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 147
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Hyperleukocytosis and leukostasis: management of a medical emergency 146
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 145
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 145
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 140
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 139
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 138
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 136
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 135
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 134
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 134
CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia 133
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 131
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 131
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 131
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 131
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 129
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 128
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 127
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation 127
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation 127
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 127
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 126
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 125
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 125
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 123
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 123
Totale 20.057
Categoria #
all - tutte 184.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 0 0 0 0 0 0 386 74
2021/20222.628 249 128 75 139 162 78 66 390 140 179 507 515
2022/20235.174 754 661 414 708 373 621 263 337 571 183 196 93
2023/20244.039 124 853 194 210 218 561 243 157 165 271 499 544
2024/20258.340 429 341 649 566 591 289 323 348 1.116 793 1.591 1.304
2025/202616.601 2.735 615 1.209 1.737 2.585 891 2.984 1.015 1.295 1.434 101 0
Totale 45.328